After stopping initial GLP-1 injections, many patients explored other treatment options: 27% switched to a different medication 20% restarted their original medication 14% continued their obesity treatment with lifestyle modification visits with health care professionals Less than 1% transitioned to undergoing metabolic and bariatric surgery Many patients do not give up on their obesity treatment journey, even if they need to stop their initial medication, said Gasoyan
The population was 65% White, 24% Asian, 7% American Indian or Alaska Native, and 3% Black or African American
Professional guidance A registered dietitian or postpartum fitness coach can tailor a safe plan for you
Type 1 predominates in the sebaceous glands and scalp, contributing directly to follicular DHT levels
Numbness and reduced sensation in the treated often occur and can persist for several weeks/months after the treatment
When GLP-1 activates receptors in your kidneys, it changes how these filters work